Erenumab versus topiramate: migraine-related disability, impact and health-related quality of life
{{output}}
Background and purpose: HER-MES was the first head-to-head study of erenumab against topiramate (standard of care). This post hoc analysis of the HER-MES study evaluated the effect of erenumab versus topiramate on patient-reporte... ...
